fludarabine has been researched along with Gastroenteritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SH; Hyun, MS; Joo, YD; Kim, DY; Kim, H; Kim, MK; Kim, SD; Lee, GW; Lee, JH; Lee, KH; Lee, WS; Min, YJ; Park, JH; Ryoo, HM | 1 |
| Björkholm, M; Celsing, F; Runarsson, G; Waldenström, J | 1 |
1 trial(s) available for fludarabine and Gastroenteritis
| Article | Year |
|---|---|
Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.
Topics: Adolescent; Adult; Aged; Busulfan; Cyclophosphamide; Drug Therapy, Combination; Female; Gastroenteritis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Myelodysplastic Syndromes; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2013 |
1 other study(ies) available for fludarabine and Gastroenteritis
| Article | Year |
|---|---|
Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenström's macroglobulinemia.
Topics: Aged; Gastroenteritis; Humans; Immunization, Passive; Immunocompromised Host; Immunoglobulins, Intravenous; Male; Mamastrovirus; Opportunistic Infections; Peptic Ulcer; Vidarabine; Virus Diseases; Waldenstrom Macroglobulinemia | 1995 |